Panaxia Global, the controlling owner of Panaxia Malta (operations) Ltd., a global pharma company that develops, manufactures and markets advanced medical cannabis products of pharmaceutical quality, has received an official license from the health authorities in Malta to manufacture finished medical cannabis products.
Production in Malta, following the adaptation of the EU-GMP standard for the facility in January by the European Health Authority, will allow immediate export from Malta and marketing of the company's finished medical cannabis products in accordance with the standards accepted by the European Authorities for the production of medical cannabis products.
